# Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients

> **NCT02939079** · PHASE2,PHASE3 · COMPLETED · sponsor: **Isfahan University of Medical Sciences** · enrollment: 50 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Fingolimod
- **DIETARY_SUPPLEMENT:** Fish Oil
- **DRUG:** Placebo (for Fish Oil)

## Key facts

- **NCT ID:** NCT02939079
- **Lead sponsor:** Isfahan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-09
- **Final completion:** 2016-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02939079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02939079, "Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02939079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*